Assessing the Cost-Effectiveness of Three-Monthly Paliperidone Palmitate Versus its Prior Monthly Formulation for the Management of Schizophrenia in the UK Setting
Abstract
Authors
C Arteaga R Nilforooshan J Lee T Ming A Bird CW van Gils